FDA scrutiny of compounded dupes is increasing as shortages ease
The global GLP-1 analogues market size was calculated at USD 66.48 billion in 2025 and is predicted to increase from USD 88.58 billion in 2026 to approximately USD 1,062.90 billion by 2035, expanding at a CAGR of 31.94% from 2026 to 2035
FDA also specifically warned patients not to use compounded drugs from a California compounding pharmacy
Cytotoxicity in mammalian cells Vero cells (African Green Monkey Kidney cells, ATCC CCL-81) were grown in Dulbeccos modified Eagles medium (DMEM) containing glucose, L-glutamine and sodium pyruvate and supplemented with 10% fetal bovine serum and 1X penicillinstreptomycin (Sigma) at 37 C in culture flasks (TPT-90025) until confluent growth was attained
5a), a pro-drug that combines sulphapyridine (an antibiotic) and 5-aminosalicylic (an anti-inflammatory agent) linked by an azo bridge, has huge therapeutic potential, but is, unfortunately, labile under physiological conditions (70% degradation by colonic bacteria via azo cleavage
